Navigation Links
SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
Date:3/20/2008

SAN DIEGO, March 20 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) will be presenting at the Future Leaders in the Biotech Industry Conference hosted by BioCentury and Thomson on Thursday, March 27, 2008 at 9:00 AM Eastern Daylight Time. Mike Grey, president and chief executive officer of SGX Pharmaceuticals, will provide an overview of the Company's oncology pipeline. The conference is being held at the Millennium Broadway Hotel and Conference Center in New York City.

A live webcast of the presentation will be available under the investor relations section of the Company's website at http://www.sgxpharma.com. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as SGX523, a MET kinase inhibitor currently in Phase 1 clinical studies, next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis and a portfolio of inhibitors of various oncology targets. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
2. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
3. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
4. Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
5. MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
7. NPS Pharmaceuticals Reports 2007 Financial Results
8. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
9. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
10. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
11. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Switzerland’s MS Tûranor PlanetSolar , the ... record for a transatlantic crossing by a solar electric ... 25, 2013, the solar powered boat sailed 2,867miles (5,310 ... of 5.3 knots before reaching Marigot, St. Martin, in ... first-of-its-kind catamaran completed this year’s passage across the Atlantic ...
(Date:5/19/2013)... MA (PRWEB) May 19, 2013 The ... social media training online, has proudly announced that the ... small business has surpassed 175,000 views on YouTube. The ... social media and SEO tips and training for small ... my students find the YouTube tips helpful for their ...
(Date:5/17/2013)... 2013 Topricin Pain Relief and ... been listed among nationally recommended over-the-counter (OTC) health ... by "U.S. News" Health in collaboration with "Pharmacy ... “No. 1 Pharmacists Recommended designation” in the “Topical ... brands, and is the only homeopathic formula to ...
(Date:5/17/2013)... 2013 Dr. Sparano is Professor of ... at the Albert Einstein College of Medicine and Associate ... Medical Center. He is also Associate Director for ... the Einstein Breast Cancer Working Group, a multidisciplinary group ... research. He also serves as Vice Chair of the ...
Breaking Biology Technology:MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... Janssen Biotech, Inc. announced today that the ... Complete Response letter for its supplemental Biologics License ... in September 2010, seeks to expand the SIMPONI® ... structural damage, inducing major clinical response (MCR) and ...
... Calif., July 22, 2011 NeurogesX, Inc. (Nasdaq: ... novel pain management therapies, today announced that on July ... in connection with a private placement to a group ... conditions, is expected to receive approximately $20 million in ...
... (previously known as the Beijing Genomics Institute), the largest ... Zoology, Chinese Academy of Sciences, together published the whole ... ) in Genome Biology on July 6th, ... for evolutionary and biomedical research. Rhesus macaque, also ...
Cached Biology Technology:FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application 2FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application 3FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application 4FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application 5FDA Issues Complete Response Letter to Janssen Biotech, Inc. for SIMPONI® Supplemental Biologic License Application 6NeurogesX, Inc. Announces $20 Million Private Placement 2NeurogesX, Inc. Announces $20 Million Private Placement 3NeurogesX, Inc. Announces $20 Million Private Placement 4Whole sequence variation map reveals insight into evolutionary studies of rhesus macaque 2
(Date:5/19/2013)... have engineered a strain of electricity-producing bacteria that can ... and carbon dioxide as its sole source of carbon. ... their findings at the 113th General Meeting of the ... result of current production solely on hydrogen," says Amit ... his co-authors are part of the Lovley Lab Group ...
(Date:5/18/2013)... 2013) Research presented today at Digestive Disease Week ... findings about the impact of coffee on autoimmune disease ... coffee consumption recently has been associated with reduced risk ... few more cups of java each month also correlate ... Researchers at the Mayo Clinic, Rochester, MN, linked coffee ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
... Ramat Rahel, located on a hilltop above modern-day Jerusalem. The ... kingdom of Biblical Judah, digs have also revealed a luxurious ... irrigation system, they could only imagine what the original garden ... Using a unique technique for separating fossilized pollen ...
... Brown University scientists have created the first three-dimensional ... analyze the effectiveness of therapeutics to combat brain tumors. ... information than Petri dish tissue cultures. The researchers ... of blood vessels that surrounds it. In a series ...
... Desert there is an ,oasis, of microorganisms. Researchers from the ... North in Chile have found it in hypersaline substrates thanks ... be used in environments similar to subsoil on Mars. ... A Spanish-Chilean team of scientists have found bacteria and archaea ...
Cached Biology News:Fossilized pollen unlocks secrets of ancient royal garden 2Fossilized pollen unlocks secrets of ancient royal garden 3Researchers make living model of brain tumor 2Microbial oasis discovered beneath the Atacama Desert 2
Cell Culture Flask, nontreated polystyrene...
... Corning CellBIND surface is produced by ... a more hydrophilic surface giving more ... growth and yields. CellBIND enhances cell ... including reduced serum or serum-free medium. ...
... array system, 100-240 V, uses xMAP technology ... 100 proteins and peptides in one microplate ... up to 100 color-coded bead sets, each ... unique reactant (enzyme substrates, receptors, antigens, or ...
... 100-240 V, is an optional module for ... delivery of up to 20 L of ... The HTF system automatically draws sheath fluid ... constantly maintain a reservoir of pressurized sheath ...
Biology Products: